References
- Obaidat A, Roth M, Hagenbuch B. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol 2012; 52:135 - 51; http://dx.doi.org/10.1146/annurev-pharmtox-010510-100556; PMID: 21854228
- Hamada A, Sissung T, Price DK, Danesi R, Chau CH, Sharifi N, et al. Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res 2008; 14:3312 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-07-4118; PMID: 18519758
- Sharifi N, Hamada A, Sissung T, Danesi R, Venzon D, Baum C, et al. A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJU Int 2008; 102:617 - 21; http://dx.doi.org/10.1111/j.1464-410X.2008.07629.x; PMID: 18537956
- Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, et al. SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2011; 29:2565 - 73; http://dx.doi.org/10.1200/JCO.2010.31.2405; PMID: 21606417
- van de Steeg E, Stránecký V, Hartmannová H, Nosková L, Hřebíček M, Wagenaar E, et al. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest 2012; 122:519 - 28; http://dx.doi.org/10.1172/JCI59526; PMID: 22232210
- Pressler H, Sissung TM, Venzon D, Price DK, Figg WD. Expression of OATP family members in hormone-related cancers: potential markers of progression. PLoS One 2011; 6:e20372; http://dx.doi.org/10.1371/journal.pone.0020372; PMID: 21625523
- Sharma P, Butters CJ, Smith V, Elsby R, Surry D. Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. Eur J Pharm Sci 2012; 47:244 - 55; http://dx.doi.org/10.1016/j.ejps.2012.04.003; PMID: 22538052